Company intelligence / Profile preview

VirTrial

Ownership: Private
Development stage: Other

Overview

VirTrial provides a commercial telemedicine and virtual site monitoring platform used by pharmaceutical companies and CROs to conduct decentralized and hybrid clinical trials, including FDA-approved decentralized studies, and was acquired by Signant Health in 2020 to expand its digital enablement and evidence generation capabilities for clinical research sites.[2][3]

Modalities: DeviceNon-pharmacological therapy
Industry: Biomedical IT and Biomedical Data Platforms

Partnerships

Hope Biosciences (hybrid decentralized clinical trial using VirTrial platform)Multiple pharmaceutical companies and CRO users of the platform (not individually named)

Beyond the preview

Go deeper on VirTrial.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on VirTrial.

Explore the full profile